Endpoints News – Biotech, drug, pharma and health news for …
WEBAll of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs. SIGN UP NOW.
News – Endpoints News
WEBThe Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry. Yesterday.
The Endpoints 11 winners: Big bets on AI, new frontiers in editing, …
WEB6 days ago · The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry
It’s mission critical this time as biotech looks to bounce back
WEBIt’s mission critical this time as biotech looks to bounce back We’ve gone quite a stretch without a live JP Morgan conference. Now it’s time to fix that. Getting together, exploring new deals, hoping someone uncorks a whopper of a buyout, all while assessing the year ahead — these are all annual traditions set to make a comeback at the start of 2023. And this year Endpoints News will ...
Endpoints 11 - Biopharma’s most promising startups in 2021
WEBSep 22, 2024 · The biotech 2.0 era has arrived. And with that backdrop, we'll unveil the top 11 companies supercharging a new generation of startups in 2021. Watch John Carroll & John Chiminski as they talk biotech with the teams behind the winning companies and learn what defines the Endpoints 11.
Endpoints at #ASCO24
WEBJun 4, 2024 · Endpoints at #ASCO24. Endpoints at #ASCO24. Tuesday, June 4, 2024. 11:00 AM - 1:40 PM. Each year, the oncology world looks to the ASCO meeting to make sense of the clinical cancer landscape. Data coming out of the meeting will signal pipeline strengths and weaknesses, and point to the next directions for cancer treatment.
Cancer breakthroughs and barriers in oncology R&D
WEBAfter a decade of patient breakthroughs leveraging technologies like immunotherapy, ADCs and targeted therapies, cancer R&D is staring down its next era. Our expert panel will look at how the R&D landscape has shifted, new attempts to go after cancer's “undruggable” targets and how the field is thinking about where the goalposts are in what ...
Endpoints at #JPM24 | Primed to unlock biopharma's next …
WEBEndpoints at #JPM24 | Primed to unlock biopharma's next dealmaking wave. An oasis has emerged in the biopharma money desert as backers look to replenish capital — still, uncertainty remains on whether it's a mirage or the much needed dealmaking bump the industry needs. Yet spirits run high as JPM24 marks the triumphant return of inking ...
Endpoints News – The biopharma world is here
WEBEndpoints News – The biopharma world is here. Get the latest reports on drug development, clinical trials, deals and more from the industry experts.
Weekly channel feed - Endpoints News
WEBMerck’s $3B return to eye disease; J&J’s $1.25B tuck-in; Keytruda challenger steals #ASCO24 show; and more. 3 months ago.